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Abstract
Background: Adipocytes contribute to inflammation and the innate immune response through expression of
inflammatory mediators. High levels of these mediators have been related to chronic inflammation state and
insulin resistance, cardiovascular diseases and diabetes type 2, among other disorders. 3-octadecylglycerol (batyl
alcohol) has been described as an inflammatory agent, whereas Conjugated Linoleic Acid (CLA) is considered
effective against obesity. In this study we examined the anti-inflammatory activity and mechanisms of modified
alkoxyglycerols. Tumor necrosis factor (TNF-a) activated mature adipocytes were used as cellular model of
inflammation. Secreted levels and gene expressions of some inflammatory mediators, such as the adipokines,
interleukin (IL)-1b, IL-6 and IL-10; and the levels of leptin and adiponectin hormones were quantified in presence
and absence of alkoxyglycerols and when human adipocyte cells were or not activated by TNF-a. The aim of this
study is to describe the effects of nonesterified alkoxyglycerols, CLA and diesterified alkoxyglycerols with CLA (DEA-
CLA) and check if they present beneficial properties using an in vitro model of some chronic diseases related to
the inflammatory process, such as obesity, using human mature adipocytes activated with TNF-a.
Results: Our data suggest that DEA-CLA, product of the esterification between the CLA and batyl alcohol, present
beneficial effects on adipocytes close to observed and described for CLA (i.e. decrease of IL-1b) and no adverse
effects as observed for batyl alcohol (i.e. decrease of IL-10). In addition, DEA-CLA presented similar activity to CLA
showing a trend to increase the secreted levels of adiponectin and decreasing the secreted levels of leptin.
Conclusions: CLA and DEA-CLA modify adipocyte inflammatory mediators and also could play a role on energy
homeostasis through depletion of leptin levels.
Background
Obesity and its pathological complications, including
atherosclerosis, hypertension, and insulin resistance,
have increased to reach epidemic dimensions nowadays
[1]. Some important factors for the development of
these disorders are excessive accumulation of abdominal
fat, which is known to play an important role in devel-
opment of chronic inflammation; deposition of lipids
into non-adipose tissues such as liver and muscles;
atherosclerosis and chronic inflammation that increase
risk in cardiovascular disorders and diabetes [2].
Adipose tissue is not just a site of energy storage but
also behaves as a dynamic endocrine organ [3], it also
plays an important role in energy expenditure, both as
depot for energy-rich triglycerides as a source for meta-
bolic hormones as well [4,5]. Adipocytes produce a large
number of so-called adipokines, such as leptin, adipo-
nectin, interleukin (IL)-1b, IL-6 and tumor necrosis fac-
tor-alpha (TNF-a). Some of these molecules affect
energy metabolism and insulin sensitivity in other tis-
sues such as muscle and liver [6]. During obesity, lipid
storage in adipocytes is increased, which triggers the
release of adipokines [7,8]. During inflammation, the
mature adipocytes of the adipose tissue are responsible
for increasing production of pro-inflammatory adipo-
kines [9], including mentioned TNF-a, IL-1b, IL-6. That
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disregulation contributes to obesity and chronic inflam-
mation [10]. The local increase of these adipokines have
been directly related to insulin resistance, increasing
lypolisis and increasing leptin levels [5]. Moreover, IL-6,
as other proteins like TNF-a and C-reactive protein, is a
clinic marker of cardiovascular risk [11].
Increased level of TNF-a in adipose tissue is closely
associated with obesity-related complications such as
insulin resistance [12], therefore providing useful thera-
peutic targets for modulating visceral obesity-related
pathologies it is a must.
Besides secretion of pro-inflammatory adipokines, adi-
pocytes are also responsible of leptin synthesis. Leptin is
a hormone that plays an important role in the regula-
tion of body mass index (BMI). In this case leptin acts
regulating appetite and on the energetic expenditure as
it encourages catabolic pathways versus anabolic path-
ways regulating 5’-AMP-activated protein kinasa
(AMPK) in muscle and liver [2]. Furthermore, leptin can
modulate the proliferation and differentiation of lym-
phoid cells of immune system and can induce the
inflammatory response [5]. Also, leptin can lead pro-
thrombotic states stimulating plaquetary aggregation at
the same time that inhibiting the coagulation and fibri-
nolysis to show a pro-atherosclerotic effect [13].
Adiponectin is a hormone synthesized exclusively in
mature adipocytes. Adiponectin is down-regulated in
obesity, diabetes type 2 and in coronary diseases. It pre-
sents anti-inflammatory activity as inhibit the synthesis
of TNF-a in adipocytes and in macrophages [13]
through the modulation of NF-kb [5]. Furthermore,
anti-atherosclerotic effects of adiponectin has been
described through its up-regulation in mouse model
(ApoE -/-) of atherosclerosis in which the formation of
atherosclerotic plaques is reduced [2].
An attractive way of reducing the chronic inflammatory
process in obesity consists on the use of natural products,
in particular, some compounds present in foods that have
been using for a long time [14]. Some of these com-
pounds, as alkoxyglycerols, have been described that
decreases the levels of pro-inflammatory cytokines and
leptin simultaneously and increase the levels of adiponec-
tin, in other words, produce anti-inflammatory effects
[15,16]. Whereas CLA is considered effective against obe-
sity [16], batyl alcohol, on contrary, has been described as
an inflammatory agent [17].
The aim of this study is to describe the effects of diester-
efied alkoxylglycerols (DEA-CLA), products of esterifica-
tion of CLA and batyl alcohol, with the activity of parental
compounds and check if they present beneficial properties
in an in vitro model of inflammation and other chronic
diseases related to the inflammatory process using human
mature adipocytes activated with TNF-a [18].
Results
In order to examine the effects of TNF-a on the adipo-
kine secretions, fully differentiated human adipocytes
were treated for different times (4, 6 y 8 hours) with
several concentration of recombinant human TNF-a
[19]. Proteins secreted into the medium were measured
by the Bradford assay as mentioned in materials and
methods. These TNF-a treated cells showed an
increased in total protein secreted (Figure 1). The
increase in protein secretion was used as indicator for
adipocyte activation. The secretion of proteins increased
from 4 hours to 8 hours, and the levels were stable at 6
hours at concentration of 10 ng/ml.
The composition of DEA-CLA analyzed by HPLC-
ELSD can be seen in Table 1.
Prior to examine the effects of lipids on adipokine
secretions, it was studied the cytotoxicity of lipids candi-
dates to study, batyl alcohol, CLA y DEA-CLA. So adi-
pocytes were incubated with several alkoxyglycerols
concentrations during 24 hours. Figure 2 shows the
effects of the studied lipids in mature adipocytes. No
significant decrease in cell viability was observed for
concentrations lower than 50 μg/ml of batyl alcohol for
incubations of 24 hours. Reduction in cell viability in a
dose dependent manner was observed for higher con-
centrations than 50 μg/ml of batyl alcohol. Similar beha-
vior was observed for CLA for concentrations higher
than 3 μl/ml. DEA-CLA did not present cytotoxicity for
concentrations lower than 200 μg/ml.
To investigate whether studied alkoxyglycerols could
modify the TNF-a-induced secretion of adipokines by
adipocytes, human adipocytes were pre-treated with
TNF-a using 10 ng/ml for 6 hours. After this period, the
induced adipocytes were treated with the highest not
toxic concentration of each lipid (batyl alcohol 50 μg/ml,
CLA 3 μl/ml and DEA-CLA 200 μg/ml) for 24 hours.
After 24 hours of incubation with CLA or DEA-CLA
on TNF-a-induced cells, the pro-inflammatory adipo-
kines IL-1b and IL-6 secretions decrease to reach the
non TNF stimulates level of the control group. In other
words, activation by TNF-a was inhibited and levels
reached control levels (Figure 3A and 3B). Treatment
with batyl alcohol did not affect secretions of non sti-
mulated groups, but levels on TNF-a-induced group
reached to non stimulated.
Regarding to the anti-inflammatory adipokine, IL-10,
batyl alcohol decreased its level in both groups, TNF-a
stimulated and non-stimulates. CLA increased signifi-
cantly the secretion levels of IL-10, also in both groups.
DEA-CLA showed to have lower effects than CLA but
higher than batyl alcohol (Figure 3C).
All lipid treatments reduced the secretion levels of
leptin significantly in TNF-a-induced and non-induced
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cells. CLA < DEA-CLA < batyl alcohol recovered the
secretion levels of non-TNF-a-induced control cells
(Figure 4A).
On contrary, all treatments increased significantly the
secretion levels of adiponectin in TNF-a-induced and
non-induced adipocytes respect control levels. CLA <
DEA-CLA < batyl alcohol recovered the secretion levels
of non-stimulated control cells (Figure 4A). On contrary
batyl alcohol decreased adiponectin levels in non-stimu-
lated cells.
24 hours treatments of cells using any of the studies
alkoxyglycerols caused a significant increment of IL-1b
gene expression of stimulated cells in TNF-a-induced
cells, but did not affect the gene expression of the non-
stimulated groups (Figure 5A).
Similar results were observed for IL-6 in all treat-
ments: gene expression increased in TNF-a-induced
cells, but was not modify in non stimulated groups
(Figure 5B).
IL-10 gene expressions were increased in cells treated
with either CLA or DEA-CLA during 24 hours and
higher increases were observed when cell were pre-sti-
mulated by TNF-a. There were not any effects when
cells were treated with batyl alcohol; levels remain in
similar levels than their respective controls.
Adiponectin gene expression was, in general term,
reduced in TNF-a-induced cells in all treatments
(Figure 6A), even in non-TNF-a-induced cells although
the reduction were less noticed in CLA treated adipo-
cytes. Treatments with any lipids caused a significant
reduction in adiponectin gene transcription.
All treatments decreased significantly the secretion
levels of leptin in all groups, TNF-a-induced and non-
induced adipocytes, respect control levels, except for
batyl alcohol in stimulated cell groups (Figure 6B).
Regarding to NF-kb, none of the treatments with any
of the studied alkoxyglycerols modified NF-kb gene
expression (Figure 7A). Levels observed in all treatments
were similar to observed to TNF-a stimulated and non-
stimulated control groups.
PPARg gene expression were no modified in non-
induced adipocytes group respect non-induced control
but were increased in TNF-a stimulated groups when
were treated either CLA or DEA-CLA although did not
recover expression levels of non-induced control group
(Figure 7B).
Discussion
As demonstrated by Ouchi et al., the mature adipocytes
are responsible of increased production of pro-inflam-
matory adipokines during inflammation [20]. Macro-
phage infiltration has been postulated to be a primary
stimulus for the inflammatory properties of adipose
tissue secreting high levels of TNF-a, which down-
regulated the expression of PPARg through the
activation of NF-kb [6,18].
Several natural compounds are known for their
beneficial properties to some diseases or their derived
complications and particularly concerning to their anti-
inflammatory effects [18,19,21]. Some of these effects
Figure 1 Levels of total protein in TNF-a induced secretion in human adipocytes. Results are shown as the means ± SEM of triplicate
determinations. Statistic Dunnett’s multiple comparison test VS Ctrl - TNF-a signification is represented by * P values less than 0.05 significant **
P values less than 0.01 very significant and *** P values less than 0.001 extremely significant.
Table 1 DEA-CLA composition determined by HPLC
coupled with Evaporative Light Scattering Detector,
results expressed as Weight %.
DEA-CLA lipid composition Weight %
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include inhibition of the TNF-a activated-NF-kb signal-
ing in adipocytes [18]. In the present study, it was stu-
died if alkoxiglycerols could play a role modifying TNF-
a-induced secretion of inflammatory adipokines in
mature adipocyte cells.
Regarding to the non-esterified alkoxyglycerol studied,
3-octadecylglycerol (batyl alcohol), it was described in
1998 by Yamamoto et al. as a potent activator of the
inflammatory process in mouse macrophages [17], but
no extensive literature could be found for this lipid. In
our experiments, batyl alcohol did not present a high
pro-inflammatory trend but levels of anti-inflammatory
adipokines, IL-10 and adiponectin were significantly
reduced.
CLA and DEA-CLA presented anti-inflammatory
activity in our experiments, since they decrease the
secretion of IL-1b and IL-6, but not their gene expres-
sions, and increase the IL-10 levels and gene expression.
At the same time recovered the levels and expression of
adiponectin and decreased levels of leptin secretions.
CLA is commonly used as nutraceutical or as a func-
tional food ingredient due to its anti-obesity effects,
demonstrated in several studies [22,23]. DEA-CLA pre-
sented characteristic effects closer to CLA, than to batyl
alcohol. Our data suggest that the esterification between
the CLA and batyl alcohol produced a compound with
properties with more benefits (i.e. decrease of IL-1b by
CLA in stimulated cells) than drawbacks (decrease of
IL-10 by batyl alcohol). Although, opposing results were
obtained regarding the decreasing levels of IL-6 and IL-
1b secretion and the increasing levels of their mRNA by
CLA or DEA-CLA treatments in activated cells, this fact
was previously described for CLA, which increased IL-6
and IL-1b gene expression in TNF-a stimulated adipo-
cytes [21]. On the other hand, DEA-CLA also presented
similar CLA activity since showed a trend to increase
the secreted levels of adiponectin and to decrease
secreted levels of leptin. All these changes could be
mediated by PPARg nuclear receptor, on TNF-a stimu-
lated cells, since its gene expression strongly decreased
after 24 h of incubation with any of the studied alkoxy-
glycerols but not in non-stimulated adipocytes. The
mechanism of action could be independent from NF-kb
at 24 hours since its expressions was not modified on
any treatment, although in general the inflammatory
mediators linked to chronic inflammation have been
shown to be regulated by NF-kB [24]. CLA consist on
dienoic isomers of linoleic acid, including trans-10, cis-
12 CLA and cis-9 trans-11 CLA. CLA isomers have
been reported to reduced body weight, reduced leptin
levels, increase PPAR g and adiponectin, but the results
are inconsistent because its been attributed to reverse
causes at the same time, insulin resistance and inflam-
mation [25,26]. Trans-10 cis-12 CLA but not cis-9
trans-11 CLA has been reported to antagonizes activity
of PPARg and consequently cells rescue mRNA levels of
PPARg [25]. On contrary, it has been demonstrated a
reduced expression of PPARg by TNF-a in adipocytes
[27]. Consequently, controversial results have been
reported about PPARg expression [15,28] after trans-10
Figure 2 Effects of alcoxyglycerols on mature adipocytes viability. Cells were treated with increasing concentrations of batyl alcohol (from 0
to 200 μg/ml) (black bars), DEA-CLA (from 0 to 200 μg/ml) (white bars) and with (striped bars) CLA (from 0 to 4 μl/ml), for 24 h. Cell viability was
determined by the MTT assay. Values represent the mean ± SEM of three independent experiments and statistic signification is represented by
** P values less than 0.01 very significant and *** P values less than 0.001 extremely significant.
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Figure 3 Effects of alcoxyglycerol treatments on TNF-a induced adipokine secretion by human adipocytes. After pre-treatment with 10
ng/ml TNF-a for 6 hours, human adipocytes were treated with 200 μg/ml DEA-CLA, 50 μg/ml batyl alcohol or 3 μl/ml of CLA. The secreted
cytokines IL-1b (A), IL-6 (B) and IL-10 (C) into the medium were measured. Results are shown as the means ± SEM of triplicate determinations.
Statistic Dunnett’s multiple comparison test VS Ctrl +TNF-a signification is represented by * P values less than 0.05 significant ** P values less
than 0.01 very significant and *** P values less than 0.001 extremely significant. Statistic “Bonferroni multiple comparison test VS Ctrl-TNF-a
signification is represented by ◆P values less than 0.05 significant, ◆◆P values less than 0.01 very significant and ◆◆◆P values less than 0.001
extremely significant.
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cis-12 CLA treatments: such as reduction of its gene
expression in 3T3-L1 adipocytes [29] and in the other
hand an increment of PPARg expression in human adi-
pocytes due a promotion of NFb activation followed by
the subsequent induction of IL-6 [30].
For a deeper study of these alkoxygycerols on TNF-a
stimulated adipocytes as cellular model of inflammation,
more experiments should be carried out such as deter-
minate secretion levels of other adipokines and their
mRNA expression, ERK phosphorylation, COX-2
expression and quantification of its products PGE2,
iNOS activity and expression.
Conclusions
Our data suggest that DEA-CLA (product of the esterifi-
cation between the CLA and batyl alcohol) presented
characteristics effects closer to CLA than to batyl alcohol.
In addition, CLA and DEA-CLA modify adipocyte
inflammatory mediators and also could have a play on
the energy homeostasis through depletion of leptin levels.
Figure 4 Effects of alcoxyglycerol treatments on TNF-a induced adipokine secretion by human adipocytes. The secreted adipokines
leptin (A), adiponectin (B) into the medium were measured. Results are shown as the means ± SEM of triplicate determinations. Statistic
Dunnett’s multiple comparison test VS Ctrl +TNF-a signification is represented by * P values less than 0.05 significant ** P values less than 0.01
very significant and *** P values less than 0.001 extremely significant. Statistic “Bonferroni multiple comparison test VS Ctrl - TNF-a signification is
represented by ◆P values less than 0.05 significant, ◆◆P values less than 0.01 very significant and ◆◆◆P values less than 0.001 extremely
significant.
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Figure 5 Effects of alcoxyglycerols on the relative 24 h transcription gene quantification (RQ) of IL-1b (A), IL-6 (B) an IL-10 (C) on
human adipocytes. Data represent means ± SEM calculated from six independent experiments with 3 replicates for each treatment. Statistic
Dunnett’s multiple comparison test VS Ctrl +TNF-a signification is represented by: * P values less than 0.05 (significant), ** P values less than 0.01
(very significant), and *** P values less than 0.001 (extremely significant). Statistic Bonferroni multiple comparison test VS Ctrl - TNF-a signification
is represented by: ◆◆ P values less than 0.01 (very significant), and ◆◆◆ P values less than 0.001 (extremely significant).
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Figure 6 Effects of alcoxyglycerols on the relative 24 h transcription gene quantification (RQ) of leptin (A) and adiponectin (B) on
human adipocytes. Data represent means ± SEM calculated from six independent experiments with 3 replicates for each treatment. Statistic
Dunnett’s multiple comparison test VS Ctrl +TNF-a signification is represented by: * P values less than 0.05 (significant), ** P values less than 0.01
(very significant), and *** P values less than 0.001 (extremely significant). Statistic Bonferroni multiple comparison test VS Ctrl - TNF-a signification
is represented by: ◆◆ P values less than 0.01 (very significant), and ◆◆◆ P values less than 0.001 (extremely significant).
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Methods
Reagents
1-O-Octadecyl-rac-glycerol or Batyl alcohol, with purity
higher than 99% w/w, was purchased from Nikko Chemi-
cals Co., Ltd. (Tokyo, JAPAN). CLA (purity of 90% w/w)
was a gift of Natural ASA (Sandvika, Norway) according
to ASA specification, CLA composition by Gas Chroma-
tography and expressed as Relative area % were Palmitic
acid C16: 0, 3.9%; Stearic acid C18:0, 2.3%; Oleic acid
C18:1 C9, 10.3%; Linoleic acid C18:2 C9, C12, 1.6%; CLA
C18: 2, conjugated, 81.8% (CLA Cis9, Trans 11 isomer,
36.7% CLA Trans10, Cis12 isomer 38.3%) TNF-a was
purchase from R&D Systems. Preadipocyte Basal Med-
ium, Fetal Bovine Serum (FBS), L-Glutamine, Penicilin,
Streptomycin, Preadipocyte Differentiation Medium,
Insulin, Dexamethasone, Indomethacin, 3-isobutyl-1-
methylxanthine and DMEM/Ham’s F-12 1:1 were
purchase from Lonza, USA.
Figure 7 Effects of alcoyglycerols on the relative 24 h transcription gene quantification (RQ) of NFb (A) and PPARg (B) on human
adipocytes. Data represent means ± SEM calculated from six independent experiments with 3 replicates for each treatment. Statistic Dunnett’s
multiple comparison test VS Ctrl +TNF-a signification is represented by: * P values less than 0.05 (significant), ** P values less than 0.01 (very
significant), and *** P values less than 0.001 (extremely significant). Statistic Bonferroni multiple comparison test VS Ctrl - TNF-a signification is
represented by: ◆◆ P values less than 0.01 (very significant), and ◆◆◆ P values less than 0.001 (extremely significant).
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Transesterification reaction
The enzymatic synthesis of diesterified alkoxyglycerols
with CLA has been previously reported [31]. Briefly,
batyl alcohol (500 mg) and CLA (818 mg) were added
to a 30 ml flask and mixed by swirling. Then the lipase
(10% w/w) was added. The flasks were placed in an
orbital shaker (200 rpm) at 55°C. Samples (30 μL) were
withdrawn periodically.
Analyses of DEA-CLA composition
The analyses were effected on a kromasil silica 60 col-
umn (250 mm by 4.6 mm, Analisis Vinicos, Tomelloso,
Spain) coupled to a CTO 10A VP 2 oven, a LC-10AD
VP pump, a gradient module FCV-10AL VP, a DGU-
14A degasser, and a evaporative light scattering detector
ELSD-LT from Shimadzu (IZASA, Spain). The ELSD
conditions were 2.2 bars, 35°C, and gain 3. The flow
rate was 2 ml/min. A splitter valve was used after the
column and only 50% of the mobile phase was directed
through the detector. The column temperature was
maintained at 35°C. The utilized mobile phase has been
previously reported by our group [32].
Cell culture
Human preadipocytes (Lonza, USA) were incubated in
Preadipocyte Basal Medium containing 10% FBS, 2 mM
L-Glutamine, 100 units/ml penicilin and 100 μg/ml
streptomycin, at 37°C, 5% CO2, in a humidified incuba-
tor up to reach 85-90% of confluence. Cells were
induced to differentiation into adipocytes by incubation
with Preadipocyte Differentiation Medium containing
insulin, dexamethasone, indomethacin and 3-isobutyl-1-
methylxanthine for 3 days. After this time, cells were
adhered to the culture dish and the medium was
replaced every 3 days for 15 days. At the end of 15 days,
cells were differentiated into adipocytes and lipid dro-
plets into the cells could be visually appreciated. After-
wards, the Adipocyte Differentiation Medium was
removed and the cells were starved in DMEM/Ham’s F-
12 1:1 for 1 day prior to assay with the plant extracts.
Cells were activated with TNF-a (10 ng/ml) for 6 h and
then treated with the different studied lipids for 24
hours. The supernatant of the different cultures were
collected and analyzed for secreted adipokines (IL-1b,
IL-6, and IL-10, leptin and adiponectin).
Citotoxicity assay
Lipids toxicity was assessed using the mitochondrial-
respiration-dependent 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium (MTT) reduction method.
Preadipocytes cells were plated in 96 wells plates, differ-
entiated and incubated with different concentrations of
lipids for 24 hours at 37°C in 5% CO2. After treatment,
the cells were washed with PBS and incubated with
MTT 1 mg/ml in PBS for 2 hours at 37°C in 5% CO2.
Afterwards, formazan crystals produced from MTT by
the mitochondrial hydrolase, only activates in viable
cells, were solubilized in lysis buffer (10% SDS in 50%
dimetilformamide pH = 7) and the absorbance of each
well was then read at 540 nm using a microplate reader
(Sunrise Remote, Tecan). The optical density of forma-
zan formed in control cells (without treatment with
extract) was taken as 100% of viability.
Bioactivity assay
Lipid extracts were dissolved in dimethyl sulfoxide
(DMSO; Sigma-Aldrich) to stock concentration of
10 mg/ml determined as the maximum dose not toxic
to cells in the citotoxicity assays. Mature adipocyte cells
were platted and differentiated in 24 well plates. After
differentiation, the cells were washed with PBS and acti-
vated with TNF-a (10 ng/ml) for 6 h and incubated
with the lipids diluted in PBS free medium, for 24 at
37°C in 5% CO2. Afterwards, the supernatant was frozen
and the cells RNA was isolated. Aliquots were analyzed
to determine secreted cytokines, leptin and adiponectin.
Total protein quantification
The Bradford method was used to determine the total
protein content in the supernatant. 5 μl of supernatant
was incubated with 250 μl of Bradford reagent (Sigma)
for 30 min in the dark at room temperature. The absor-
bance at 595 was measured and the protein concentra-
tion determined using a standard curve.
Enzyme-Linked Immuno Sorbent Assay for quantification
of cytokines
The supernatant of the different treatment were col-
lected. The concentrations of IL-1b, IL-6 and IL-10
were assayed using ELISA kits from BD Biosciences, and
leptin and adiponectin were assayed using ELISA kits
from R&D Systems. Absorbances were read at 450 nm
with l correction at 570 nm using a microplate reader
(Sunrise Remote, Tecan Austria GmbH, Grödig, Aus-
tria). Each concentration was determined from the stan-
dard curve and expressed as % of non-activated controls.
Total RNA isolation
Total RNA from adipocytes was isolated using the Tri-
zol® reagent from Invitrogen. 9.000 cells were homoge-
nized in 200 μl of Trizol® reagent and, if necessary,
stored at -80°C. Following homogenization, samples
were let to rest at room temperature for 5 minutes.
Afterwards, 40 μl of chloroform was added, the tubes
vigorously shaken for 15 seconds and let to rest at room
temperature for 5 minutes. Tubes were then centrifuged
at 12000 g (VWR, Galaxy 4D, diameter 14 cm), 4°C for
15 minutes. The aqueous (upper and colorless) phase
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was transferred to a new tube. 100 μl of isopropyl alco-
hol was added to the aqueous phase; the tube was then
gently mixed and incubated at room temperature for 10
minutes. After incubation, samples were centrifuged at
12000 g, 4°C for 10 minutes. A gel-like pellet was
formed and the isopropyl alcohol removed. The pellet
was washed with 200 ml of 75% Ethanol in DEPC trea-
ted H2O, and centrifuged at 7600 g, 4°C for 5 min. The
ethanol was then removed and the pellet let to dry until
colorless. Total RNA was then dissolved in 15 μl of
DEPC H2O, incubated at 55°C for 10 minutes and
stored at -80°C for future use.
Gene expression quantification
IL-1b, IL-6, IL-10, leptin, adiponectin and 18sRNA gene
expression were quantified using real-time PCR. 10 ng/μl
of total RNA isolated from mature adipocytes cells was
used as template for cDNA synthesis using the High
Capacity Archive Kit from Applied Biosystems, according
to the manufacturer’s instructions. Real-time PCR was
performed using Taqman Probes (Applied Biosystems)
following the manufacturer’s recommendations. The
Taqman probes used were: Hs99999029_m1 for IL-1b,
Hs00174131_m1 for IL-6, Hs999999035_m1 for IL-10,
Hs00174877_m1 for leptin, Hs00605917_m1 for adipo-
nectin, Hs00765730_m1 for NFB, Hs01115729_m1 for
PPARgamma and Hs99999901_s1 for 18sRNA. Gene
expression levels were then normalized to 18sRNA
expression and compared to it.
Statistical analysis
All data were expressed as the mean ± SEM. For single
variable comparisons, Student’s t-test was used. For
multiple variable comparisons, data were analyzed by
one-way analysis of variance (ANOVA) followed by
Dunnett’s test using SigmaStat statistical software (Win-
dows Version 5.0 Systat Software Inc., Point Richmond,
CA, USA). P values less than 0.05 were considered
significant.
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